Charles River Laboratories (CRL)

Operating profit margin

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Operating income (ttm)	US$ in thousands	617,261	648,149	647,623	670,089	650,975	659,972	664,798	614,937	589,862	545,982	522,933	462,151	432,729	412,591	372,640	375,640	351,151	344,844	336,404	333,346
Revenue (ttm)	US$ in thousands	4,097,200	4,325,190	4,303,632	4,238,180	4,106,274	3,792,022	3,683,743	3,605,712	3,459,843	3,333,185	3,172,755	2,930,880	2,859,828	2,759,976	2,697,739	2,671,095	2,595,709	2,506,101	2,411,563	2,341,443
Operating profit margin		15.07%	14.99%	15.05%	15.81%	15.85%	17.40%	18.05%	17.05%	17.05%	16.38%	16.48%	15.77%	15.13%	14.95%	13.81%	14.06%	13.53%	13.76%	13.95%	14.24%

December 31, 2023 calculation

Operating profit margin = Operating income (ttm) ÷ Revenue (ttm)
= $617,261K ÷ $4,097,200K
= 15.07%

The operating profit margin of Charles River Laboratories has shown variation over the past several quarters. The margin was relatively stable around the 15-16% range in the recent quarters of 2023, with values ranging from 14.99% to 15.81%. However, it experienced a decline in the latter part of 2022, dropping from 17.40% in September 2022 to 15.07% in December 2023. Prior to this decline, the operating profit margin had shown a generally upward trend from 2020 to mid-2022, reaching a peak of 18.05% in June 2022.

Overall, the operating profit margin of Charles River Laboratories has demonstrated some fluctuation, indicative of potential shifts in the company's profitability and efficiency in managing operating expenses relative to revenue. Further analysis of the company's financial performance and strategies may be needed to fully understand the factors driving these fluctuations.